Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]UNC Lineberger Comprehensive Cancer Center"
Count: 283
Selected: 0
NCT IDTitle
NCT04432753Effect of Incidental Findings Information on Lung Cancer Screening Intent
NCT04585893Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in Malawi
NCT04978350Overcoming Barriers to the Uptake of Cascade Screening for Lynch Syndrome: Workbook Feasibility Study
NCT01316146Administration of T Lymphocytes for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma (CART CD30)
NCT02835911Clinical Cohort of Lymphoma Patients in Malawi
NCT02660710Rituximab Plus CHOP Chemotherapy for Diffuse Large B-cell Lymphoma
NCT03544268Academic-Industrial Partnership for Translation of Acoustic Angiography
NCT04092257HPV-Based Screen-and-Treat Demonstration Project in Lilongwe
NCT04999085Geriatric-assessment Interventions to Address Functional Deficits in Older Adults w Multiple Myeloma
NCT04836455Impact of Vaping Prevention Advertisements
NCT04974489Correcting Public Misperceptions About Very Low Nicotine Content Cigarettes
NCT02651883Effect of Human Papillomavirus Self-Collection on Cervical Cancer Screening in High Risk Women: My Body, My Test 3
NCT02564120North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS)
NCT03263442High Dose Intravenous Thiamine for the Prevention of Delirium in Allogeneic Hematopoietic Stem Cell Transplantation
NCT02768792High Dose Cytarabine Followed by Pembrolizumab in Relapsed/Refractory AML
NCT03760536Get REAL and HEEL Research Program
NCT04134325Study of PD-1 Inhibitors After CD30.CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma
NCT04492007Feasibility Testing of Patient Reported Outcomes - Informed Symptom Management System (PRISMS)
NCT03885830Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients
NCT03160209HIV and Other Risk Factors for Esophageal Squamous Cell Carcinoma in Malawi
NCT04931251Addressing Cancer-Related Financial Toxicity in Rural Oncology Care Settings
NCT01137825Registry of Older Patients With Cancer
NCT04083495CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma
NCT04092816Fathers and Mothers Invested in Lives of Their Youth (FAMILY) Study: A Pilot Intervention
NCT041369123-D Super Resolution Ultrasound Microvascular Imaging
NCT04076696Clinical Evaluation of Primary Sampling Scatter Correction for Chest Tomosynthesis
NCT04644419Chemotherapy-related Cognitive Impairment and Acute Leukemia
NCT04243941PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer
NCT03977233Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
NCT03620019Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma
NCT03264131BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma
NCT04025229High Intensity Interval Training in Endometrial Cancer
NCT02690558Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy
NCT03761706Impact of Home-based Aerobic and Strength Exercises During Chemotherapy for Early Breast Cancer on Biomarkers of Aging
NCT01000883Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
NCT04990934Transitioning Care: Perspectives of Older Women With Early Breast Cancer on Current Telemedicine Modalities
NCT02008058Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer
NCT03820024MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback
NCT04504201Patient-centered Communication About Healthy Weight in Early Breast Cancer
NCT04923997The HealthScore Health Coaching Program
NCT03785782ARFI, VisR and DDAI Ultrasound for Improving Discrimination of Malignant and Unresponsive Breast Cancer
NCT04548648LCCC1841: A Phase 2 Trial of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas
NCT03016377Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL
NCT04266730Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Concurrently With Pembrolizumab
NCT04406714Scaling CRC Screening Through Outreach, Referral, and Engagement (SCORE)
NCT04670068Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian
NCT04223765Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
NCT03721068Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
NCT03602157Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL
NCT03089606Pembrolizumab TX-naive Distant Mets Melanoma and Use of (C11-AMT) PET at Baseline as Imaging Biomarker